Michael Weig - Concepedia

Author

Michael Weig

Universitätsmedizin Göttingen

Also Known As

M Weig, M. S. Weig, M. Weig, Michael Weig, Weig, Michael

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Universitätsmedizin Göttingen University of Göttingen University of Würzburg Robert Koch Institute University of Amsterdam

About

Michael Weig is an author at Universitätsmedizin Göttingen specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.3K
2	Health Sciences	5	5	535
3	Natural Sciences	4	4	454
4	Biochemistry	4	4	601
5	Engineering	1	1	40

Michael Weig

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry Oliver Bader, Michael Weig, Liliane Taverne-Ghadwal, Clinical Microbiology and Infection Human Pathogenic YeastsBiochemistryMedicineNatural SciencesBioanalysis	2010	226
The Cell Wall of the Human Pathogen <i>Candida glabrata</i> : Differential Incorporation of Novel Adhesin-Like Wall Proteins Piet W. J. de Groot, Eefje A. Kraneveld, Qing Yin, Eukaryotic Cell	2008	221
Identification and Characterization of Four Azole-Resistant <i>erg3</i> Mutants of <i>Candida albicans</i> Claire M. Martel, Josie E. Parker, Oliver Bader, Antimicrobial Agents and Chemotherapy Total Sterol FractionFungal Cell BiologyGeneticsClinical MycologyAntimicrobial Chemotherapy	2010	165
A Clinical Isolate of <i>Candida albicans</i> with Mutations in <i>ERG11</i> (Encoding Sterol 14α-Demethylase) and <i>ERG5</i> (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B Claire M. Martel, Josie E. Parker, Oliver Bader, Antimicrobial Agents and Chemotherapy Clinical IsolateTotal Sterol FractionFungal Cell BiologyPathologyClinical Mycology	2010	160
<i>cyp51A</i> -Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany Oliver Bader, Michael Weig, Utz Reichard, Antimicrobial Agents and Chemotherapy Drug Resistance AnalysisAntifungal AgentHealth SciencesBiochemistryResistant Isolates	2013	122
Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005 Margarete Borg‐von Zepelin, Luisa Kunz, R. Rüchel, Journal of Antimicrobial Chemotherapy	2007	112
Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in <i>ERG11</i> and Exhibiting Cross-Resistance to Azoles and Amphotericin B Claire M. Hull, Josie E. Parker, Oliver Bader, Antimicrobial Agents and Chemotherapy	2012	111
Systematic identification in silico of covalently bound cell wall proteins and analysis of protein-polysaccharide linkages of the human pathogen Candida glabrata Michael Weig Microbiology	2004	104
Rapid Discrimination of Salmonella enterica Serovar Typhi from Other Serovars by MALDI-TOF Mass Spectrometry Martin Kuhns, Andreas E. Zautner, Wolfgang Rabsch, PLoS ONE Pathogen DetectionBlood Culture IsolatesImmunologyMaldi-tof Mass SpectrometrySerovar Typhi	2012	102
Environmental Isolates of Azole-Resistant Aspergillus fumigatus in Germany Oliver Bader, Jana Tünnermann, Anna Dudakova, Antimicrobial Agents and Chemotherapy	2015	94

Page 1